BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22715394)

  • 21. Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.
    Li X; Galipeau PC; Sanchez CA; Blount PL; Maley CC; Arnaudo J; Peiffer DA; Pokholok D; Gunderson KL; Reid BJ
    Cancer Prev Res (Phila); 2008 Nov; 1(6):413-23. PubMed ID: 19138988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA damage and oxidative stress response to selenium yeast in the non-smoking individuals: a short-term supplementation trial with respect to GPX1 and SEPP1 polymorphism.
    Jablonska E; Raimondi S; Gromadzinska J; Reszka E; Wieczorek E; Krol MB; Smok-Pieniazek A; Nocun M; Stepnik M; Socha K; Borawska MH; Wasowicz W
    Eur J Nutr; 2016 Dec; 55(8):2469-2484. PubMed ID: 26658762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.
    Maley CC; Galipeau PC; Li X; Sanchez CA; Paulson TG; Blount PL; Reid BJ
    Cancer Res; 2004 Oct; 64(20):7629-33. PubMed ID: 15492292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of selenium status and antioxidant effect in workers occupationally exposed to mercury.
    Kuras R; Reszka E; Wieczorek E; Jablonska E; Gromadzinska J; Malachowska B; Kozlowska L; Stanislawska M; Janasik B; Wasowicz W
    J Trace Elem Med Biol; 2018 Sep; 49():43-50. PubMed ID: 29895371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression.
    Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM
    Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential responses to selenomethionine supplementation by sex and genotype in healthy adults.
    Combs GF; Jackson MI; Watts JC; Johnson LK; Zeng H; Idso J; Schomburg L; Hoeg A; Hoefig CS; Chiang EC; Waters DJ; Davis CD; Milner JA
    Br J Nutr; 2012 May; 107(10):1514-25. PubMed ID: 21936966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett's esophagus: Case series and findings.
    Marketkar S; Li D; Yang D; Cao W
    World J Gastroenterol; 2017 Feb; 23(8):1338-1344. PubMed ID: 28293080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.
    Maru DM; Singh RR; Hannah C; Albarracin CT; Li YX; Abraham R; Romans AM; Yao H; Luthra MG; Anandasabapathy S; Swisher SG; Hofstetter WL; Rashid A; Luthra R
    Am J Pathol; 2009 May; 174(5):1940-8. PubMed ID: 19342367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression to cancer in Barrett's esophagus is associated with genomic instability.
    Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
    Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
    Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):745-52. PubMed ID: 12163328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.
    Merlo LM; Shah NA; Li X; Blount PL; Vaughan TL; Reid BJ; Maley CC
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1388-97. PubMed ID: 20947487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
    J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variants in selenoprotein genes modulate biomarkers of selenium status in response to Brazil nut supplementation (the SU.BRA.NUT study).
    Donadio JLS; Rogero MM; Guerra-Shinohara EM; Barbosa F; Desmarchelier C; Borel P; Sneddon AA; Hesketh JE; Cozzolino SMF
    Clin Nutr; 2019 Apr; 38(2):539-548. PubMed ID: 29609868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary selenium deficiency or selenomethionine excess drastically alters organ selenium contents without altering the expression of most selenoproteins in mice.
    Akahoshi N; Anan Y; Hashimoto Y; Tokoro N; Mizuno R; Hayashi S; Yamamoto S; Shimada KI; Kamata S; Ishii I
    J Nutr Biochem; 2019 Jul; 69():120-129. PubMed ID: 31078905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial DNA deletions in patients with esophagitis, Barrett's esophagus, esophageal adenocarcinoma and squamous cell carcinoma.
    Keles M; Sahin I; Kurt A; Bozoglu C; Simsek G; Kabalar E; Tatar A
    Afr Health Sci; 2019 Mar; 19(1):1671-1676. PubMed ID: 31148997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex.
    Méplan C; Crosley LK; Nicol F; Horgan GW; Mathers JC; Arthur JR; Hesketh JE
    Am J Clin Nutr; 2008 Apr; 87(4):1019-27. PubMed ID: 18400727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.
    Bani-Hani K; Martin IG; Hardie LJ; Mapstone N; Briggs JA; Forman D; Wild CP
    J Natl Cancer Inst; 2000 Aug; 92(16):1316-21. PubMed ID: 10944553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference of selenium and selenoproteins with the insulin-regulated carbohydrate and lipid metabolism.
    Steinbrenner H
    Free Radic Biol Med; 2013 Dec; 65():1538-1547. PubMed ID: 23872396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.
    Blount PL; Galipeau PC; Sanchez CA; Neshat K; Levine DS; Yin J; Suzuki H; Abraham JM; Meltzer SJ; Reid BJ
    Cancer Res; 1994 May; 54(9):2292-5. PubMed ID: 8162566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.